MacTel Laser Study

Macular Telangiectasia Clinical Trial

Official title:
Controlled Pilot Study for Safety and Efficacy of Subthreshold Photothermal Therapy for Patients With Macular Telangiectasia (MacTel) Type 2

Status Completed

Clinical Trial Summary

This is a two armed Single Masked Pilot Study enrolling participants with Macular Telangiectasia Type 2 who will be randomized to undergo either a subthreshold photothermal treatment or a sham procedure to one eye. The participants will be followed for one year with visits at 1 month, 3 months, 6 months and 12 months post-treatment (laser or sham). Due to the small number of participants enrolled in this study the data will be analyzed by descriptive statistics and exploratory figures. Summary statistics will be produced for study and fellow eyes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03321916
Study type	Interventional
Source	The Lowy Medical Research Institute Limited
Contact
Status	Completed
Phase	N/A
Start date	February 8, 2018
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00685854` - Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth	Phase 1
Completed	`NCT03071965` - Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)	Phase 2
Recruiting	`NCT01975103` - Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases	Phase 2
Recruiting	`NCT03845049` - Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1	Phase 3